"At IACS, our singular goal is to provide patients access to novel therapies, and along the way do this in a cost-effective way. It’s a matter of accelerating meritorious programs, while reaching rapid decisions to stop “no-go,” ineffective projects before making large expenditures of money, time and other resources.
What we do in oncology drug discovery really counts. I remember reading a blog a few years ago when I was at Merck that really drove this point home for me. The post was written by the husband of a patient who was responding to a drug I’d developed, the PARP inhibitor niraparib. He shared a sense of hope and encouraged others to join the clinical trial.
That day was special. It showed me that what we do, creating more treatment opportunities, makes a difference in the lives of patients and their families everywhere. I want to do that again.
None of this would be possible without philanthropy. The generosity of donors who believe in our work enables us to execute on projects of great magnitude. It gives us resources to determine where those medicines are going to be effective and get them into patient use at MD Anderson and across the world.
Engineering all the necessary properties for a single molecule to be effective in patients is a challenging process that requires multiple skill sets, with collaboration and teamwork across many disciplines. We’re unique in the way we embed drug discovery experts within MD Anderson’s world-class infrastructure, collaborating with physician-scientists and clinical researchers to move forward programs that are going to be really impactful.
The hard work of the talented cross-functional teams at IACS and MD Anderson’s Center for Co-Clinical Trials is what makes things happen. The team spirit across the group is phenomenal. I hope our collaborative effort becomes the standard for moving medicines more quickly and effectively through clinical development and getting them to the right patients much earlier."
To learn more about Philip Jones, Ph.D., visit his faculty profile.